Air Liquide is to expand its healthcare business in Japan with the announcement it has acquired Sogo Sangyo Kabushiki Kaisha (SSKK), a major Japanese player with a strong presense in the home healthcare and medical gases markets.
With this acquisition, Air Liquide strengthens its footprint in Japan both in the medical gases to hospitals, and in home healthcare business.
Well known for its medical staffs’ know-how, SSKK has more than 150 employees and generated revenue of approximately €27m ($31.7m) in 2016.
Air Liquide will continue growing the company with the support of the existing team, gasworld understands.
Speaking about the deal, François Jackow, member of the Air Liquide Group’s Executive Committee, supervising the Healthcare activities, said, “With this acquisition Air Liquide pursues the development of its Healthcare activity in a growing Asian market that benefits from a strong potential. We are delighted to welcome SSKK’s teams in Air Liquide Group. Thanks to their know-how combined with Air Liquide expertise, we will deliver greater value to healthcare professionals and patients. This acquisition, which allows us to develop our activities in Japan, will also fuel our future growth.”
Present in the Japanese market for 60 years, SSKK is specialized in the medical gases field serving more than 2,000 hospitals and clinics and home treatment for patients suffering from respiratory diseases including; sleep apnea, Chronic Obstructive Pulmonary Disease and chronic respiratory failure.
The Tier One company said worldwide Japan now ranks as the third-largest Respiratory Home Healthcare market after the US and France.